InsiderFlow

SYRE

Spyre Therapeutics, Inc.$68.89-3.01 (-4.19%)
Prev Close$71.90·MCap$4.21B·P/E·Vol773.6K·Yield

Buys (12M)

0

$0.00

Sells (12M)

8

$4.24M

Net Activity

Net Seller

$4.24M

Active Insiders

3

last 12 mo

Over the past 12 months, insider activity at Spyre Therapeutics, Inc. (SYRE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 8 insider sales totaling $4.24M. The most recent insider transaction was by Burrows Scott L (officer: Chief Financial Officer), who sold $370.1K worth of shares on Apr 3, 2026. Spyre Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.21B.

SYRE Insider Trading Activity

DateInsiderTypeValue
Apr 3, 2026 Burrows Scott LSell$370.1K
Apr 3, 2026 Sloan SheldonSell$397.9K
Apr 3, 2026 Turtle CameronSell$739.9K
Feb 2, 2026 Turtle CameronSell$492.0K
Jan 2, 2026 Turtle CameronSell$460.1K
Dec 1, 2025 Turtle CameronSell$435.4K
Nov 3, 2025 Turtle CameronSell$1.05M
Sep 2, 2025 Burrows Scott LSell$299.6K
Nov 8, 2024 Albers Jeffrey W.Sell$246.3K
Oct 28, 2024 Albers Jeffrey W.Sell$10.9K
Sep 5, 2024 Burrows Scott LSell$522.1K
Aug 25, 2022 Souza MarcioBuy$50.5K
Jun 10, 2022 Hanley Jr. Michael ConickBuy$20.0K
Mar 18, 2022 Quinn Anthony G.Buy$187.7K
Mar 15, 2022 Alspaugh JonathanBuy$156.0K
Mar 15, 2022 Quinn Anthony G.Buy$280.9K
Dec 13, 2021 Alspaugh JonathanBuy$186.0K
Dec 13, 2021 Quinn Anthony G.Buy$199.0K
Dec 13, 2021 Shanafelt ArmenBuy$549.7K
Aug 18, 2021 Alspaugh JonathanBuy$262.7K

SYRE Insider Buying Activity

The following table shows recent insider purchases of Spyre Therapeutics, Inc. (SYRE) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Aug 25, 2022 Souza MarcioBuy$50.5K
Jun 10, 2022 Hanley Jr. Michael ConickBuy$20.0K
Mar 18, 2022 Quinn Anthony G.Buy$187.7K
Mar 15, 2022 Alspaugh JonathanBuy$156.0K
Mar 15, 2022 Quinn Anthony G.Buy$280.9K
Dec 13, 2021 Alspaugh JonathanBuy$186.0K
Dec 13, 2021 Quinn Anthony G.Buy$199.0K
Dec 13, 2021 Shanafelt ArmenBuy$549.7K
Aug 18, 2021 Alspaugh JonathanBuy$262.7K

SYRE Insider Selling Activity

The following table shows recent insider sales of Spyre Therapeutics, Inc. (SYRE) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Apr 3, 2026 Burrows Scott LSell$370.1K
Apr 3, 2026 Sloan SheldonSell$397.9K
Apr 3, 2026 Turtle CameronSell$739.9K
Feb 2, 2026 Turtle CameronSell$492.0K
Jan 2, 2026 Turtle CameronSell$460.1K
Dec 1, 2025 Turtle CameronSell$435.4K
Nov 3, 2025 Turtle CameronSell$1.05M
Sep 2, 2025 Burrows Scott LSell$299.6K
Nov 8, 2024 Albers Jeffrey W.Sell$246.3K
Oct 28, 2024 Albers Jeffrey W.Sell$10.9K
Sep 5, 2024 Burrows Scott LSell$522.1K

SYRE Insiders

Sloan Sheldon

officer: Chief Medical Officer

Sold $397.9K
1 tradesLast: Apr 3, 2026
Turtle Cameron

director, officer: Chief Executive Officer

Sold $3.18M
5 tradesLast: Apr 3, 2026
Burrows Scott L

officer: Chief Financial Officer

Sold $1.19M
3 tradesLast: Apr 3, 2026
Albers Jeffrey W.

Director

Sold $257.2K
2 tradesLast: Nov 8, 2024
Souza Marcio

Director

Bought $50.5K
1 tradesLast: Aug 25, 2022
Hanley Jr. Michael Conick

Chief Commercial Officer

Bought $20.0K
1 tradesLast: Jun 10, 2022
Quinn Anthony G.

President & CEO

Bought $667.6K
3 tradesLast: Mar 18, 2022
Alspaugh Jonathan

Chief Financial Officer

Bought $604.7K
3 tradesLast: Mar 15, 2022
Shanafelt Armen

Director

Bought $549.7K
1 tradesLast: Dec 13, 2021